sulotroban has been researched along with aspirin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 12 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giessler, C; Heinroth-Hoffmann, I; Mest, HJ | 1 |
| oude Egbrink, MG; Reneman, RS; Slaaf, DW; Tangelder, GJ | 2 |
| Karasawa, A; Kubo, K; Shirakura, S | 1 |
| Bhakdi, S; Eberspächer, B; Grimminger, F; Holland, IB; Hugo, F; Obernitz, R; Seeger, W; Suttorn, N; Thomas, M; Walmrath, D | 1 |
| Bass, TA; Bove, AA; Cowley, M; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, AS; Vetrovec, G; Whitworth, HB | 1 |
| Horton, AA; Wood, JM | 1 |
| Cattaneo, M; Lecchi, A; Mannucci, PM; Tenconi, PM | 1 |
| Goldberg, S; Shi, Y; Walinsky, P; Zalewski, A | 1 |
| Kienast, J; Verstraete, M | 1 |
| Barbenel, JC; Forbes, CD; Lowe, GD; Madhok, R; Saniabadi, AR; Shaw, B; Spowart, K | 1 |
| Stürzebecher, S; Witt, W | 1 |
| Ciabattoni, G; Cinotti, GA; Feriozzi, S; Mavrikakis, G; Patrignani, P; Patrono, C; Pecci, G; Pierucci, A; Simonetti, BM | 1 |
| Arnout, J; Deckmyn, H; Gresele, P; Huybrechts, E; Pieters, G; Vermylen, J | 1 |
| Berk, L; van der Giessen, WJ; Verdouw, PD; Zijlstra, FJ | 1 |
| Feldhoff, CM; Gresele, P; Pieters, G; Vermylen, J | 1 |
| Köhler, AH; Köhler, AR; Mest, HJ; Taube, C | 1 |
| Hiller, E; Höfling, B; Riess, H; von Arnim, T | 1 |
| Mest, HJ; Riedel, A | 1 |
| Patscheke, H; Stegmeier, K | 1 |
| Köhler, AH; Köhler, AR; Martin, S; Mest, HJ; Taube, C | 1 |
| Bass, T; Bove, AA; Deutsch, E; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, A; Vetrovec, G; Whitworth, HB | 1 |
| Becker, K; Bigl, H; Braquet, P; Förster, W; Lueddeckens, G; Sperling, J | 1 |
| Boshkov, LK; Etches, WS; Gordon, PA; Mant, MJ; Shaw, AR; Stewart, MW | 1 |
1 review(s) available for sulotroban and aspirin
| Article | Year |
|---|---|
Pharmacology of the interaction between platelets and vessel wall.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Dextrans; Diltiazem; Dipyridamole; Epoprostenol; Humans; Imidazoles; Ketanserin; Piperidines; Pyrazoles; Pyrazolones; Sulfinpyrazone; Sulfonamides; Thiophenes; Ticlopidine | 1986 |
5 trial(s) available for sulotroban and aspirin
| Article | Year |
|---|---|
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Mid-Atlantic Region; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Prostaglandin; Receptors, Thromboxane; Recurrence; Sulfonamides; Thromboxanes | 1991 |
Improvement of renal function with selective thromboxane antagonism in lupus nephritis.
Topics: Adolescent; Adult; Aged; Aspirin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Kidney; Lupus Nephritis; Male; Middle Aged; Random Allocation; Renal Circulation; Sulfonamides; Thromboxane A2 | 1989 |
Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Bleeding Time; Cyclooxygenase Inhibitors; Hemostasis; Humans; Imidazoles; Indomethacin; Male; Platelet Aggregation; Prostaglandins; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane-A Synthase | 1987 |
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Bleeding Time; Blood Platelets; Clinical Trials as Topic; Collagen; Cyclooxygenase Inhibitors; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxanes | 1986 |
Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Sulfonamides; Thromboxane A2; Time Factors; Treatment Outcome | 1995 |
18 other study(ies) available for sulotroban and aspirin
| Article | Year |
|---|---|
Relevance of vasoactive mediators for the blood pressure effects of intravenous arachidonic acid injection in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Aspirin; Blood Pressure; Cyproheptadine; Diterpenes; Ginkgolides; Imidazoles; Injections, Intravenous; Lactones; Male; Naphthalenes; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane B2 | 1992 |
Influence of platelet-vessel wall interactions on leukocyte rolling in vivo.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Female; Leukocytes; Male; Platelet Aggregation; Rabbits; Reference Values; Sulfonamides; Thromboembolism | 1992 |
Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Benzimidazoles; Benzoxepins; Blood Pressure; Death, Sudden; Dose-Response Relationship, Drug; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane A2; Thromboxanes; Ticlopidine | 1991 |
Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Capillary Permeability; Epoprostenol; Escherichia coli; Female; Hemolysin Proteins; Hypertension, Pulmonary; In Vitro Techniques; L-Lactate Dehydrogenase; Lung; Male; Neutrophils; Perfusion; Potassium; Pulmonary Artery; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Respiratory Insufficiency; Sulfonamides; Thromboxane B2; Thromboxanes | 1991 |
A possible role for eicosanoids in ATP-induced plasma membrane bleb formation in isolated hepatocytes.
Topics: Adenosine Triphosphate; Animals; Aspirin; Cell Membrane; Cells, Cultured; Cortisone; Cyclooxygenase Inhibitors; Eicosanoids; Imidazoles; Kinetics; Liver; Naproxen; Phospholipases A; Quinacrine; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane-A Synthase | 1991 |
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Drug Interactions; Female; Humans; Male; Malondialdehyde; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Sulfonamides; Thromboxane B2 | 1991 |
Does antiplatelet therapy enhance myocardial salvage after coronary reperfusion?
Topics: Animals; Aspirin; Dogs; Fibrinolytic Agents; Heart Diseases; Hemodynamics; Hemorrhage; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Platelet Aggregation Inhibitors; Streptokinase; Sulfonamides | 1990 |
Red blood cells mediate spontaneous aggregation of platelets in whole blood.
Topics: 2-Chloroadenosine; Adenosine; Adult; Aged; Aspirin; Epoprostenol; Erythrocytes; Humans; Iloprost; In Vitro Techniques; Middle Aged; Platelet Aggregation; Platelet Count; Sulfonamides; Thrombosis | 1987 |
The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Drug Synergism; Epoprostenol; Fatty Acids, Unsaturated; Humans; Hydrazines; Iloprost; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1988 |
The effect of the thromboxane receptor antagonist BM 13.177 on experimentally induced coronary artery thrombosis in the pig.
Topics: Animals; Anti-Arrhythmia Agents; Aspirin; Coronary Disease; Coronary Thrombosis; Electric Stimulation; Hemodynamics; In Vitro Techniques; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Swine; Thromboxane B2 | 1988 |
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits.
Topics: Animals; Aspirin; Endotoxins; Female; Imidazoles; Male; Methylprednisolone; Phthalic Acids; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Shock, Septic; Sulfonamides; Thromboxane-A Synthase | 1988 |
Decrease in arterial blood pressure in spontaneously hypertensive rats by the TXA2 receptor antagonist BM 13177 and by acetylsalicylic acid.
Topics: Animals; Anti-Arrhythmia Agents; Aspirin; Blood Pressure; Female; Male; Rats; Rats, Inbred SHR; Receptors, Prostaglandin; Receptors, Thromboxane; Reference Values; Sulfonamides | 1988 |
The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.
Topics: Animals; Arachidonic Acids; Arrhythmias, Cardiac; Aspirin; Fibrinolytic Agents; Guinea Pigs; Lipoxygenase Inhibitors; Ouabain; Platelet Activating Factor; Sulfonamides; Umbelliferones | 1987 |
Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Blood Platelets; Collagen; Humans; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Serotonin; Sulfonamides; Thrombin; Thromboxane A2; Thromboxanes | 1985 |
Influence of acetylsalicylic acid and BM 13177 on blood pressure and efficacy of antihypertensive drugs in spontaneously hypertensive rats.
Topics: Animals; Aspirin; Blood Pressure; Clonidine; Dihydralazine; Fibrinolytic Agents; Propranolol; Rats; Rats, Inbred SHR; Reference Values; Sulfonamides | 1988 |
Different roles of prostaglandins in thromboembolic processes in arterioles and venules in vivo.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arterioles; Aspirin; Epoprostenol; Female; Hydroxyeicosatetraenoic Acids; Leukocytes; Male; Mesentery; Platelet Activation; Prostaglandins; Rabbits; Receptors, Thromboxane; Regional Blood Flow; Sulfonamides; Thromboembolism; Thromboxane A2; Venules; Videotape Recording | 1993 |
Importance of secondary TXA2 release in mediating of endothelin-1 induced bronchoconstriction and vasopressin in the guinea-pig.
Topics: Animals; Aspirin; Blood Pressure; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Endothelins; Guinea Pigs; Imidazoles; Male; Naphthalenes; Prostaglandin-Endoperoxide Synthases; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Vasopressins | 1993 |
Platelet activation by a novel solid-phase agonist: effects of VWF immobilized on polystyrene beads.
Topics: Aspirin; Blood Coagulation Disorders; Contusions; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Male; Microspheres; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Sulfonamides; von Willebrand Factor | 1997 |